

Adverse drug reaction in older outpatients- An updated Review
Abstract
Adverse drug reactions (ADRs) continue to be a global health concern. They have an impact on treatment results, raise hospital admission rates, raise morbidity and death rates, and raise therapy costs, lower quality of life, and lower patient satisfaction with healthcare. The purpose of this chapter is to go over topics pertaining to adverse drug reactions (ADRs), such as their types, histories, causes, reporting, and management. With the ultimate goal of enhancing procedures in these countries, it also seeks to draw attention to the challenges that ADRs and their reporting in developing countries face, as well as to provide solutions for these challenges.
The International Classification of Diseases will eventually incorporate the WHO's Adverse Reaction Terminology, which is now used to report such reactions. The six categories of adverse medication reactions are as follows (complete with mnemonics): withdrawal (end of use), therapeutic failure (failure), dose-related and time-related (chronic), non-dose-related (bizarre), withdrawal (augmented), and withdrawal (time-related). When determining the cause of a suspected adverse drug reaction, factors such as timing, sickness pattern, investigation findings, and retesting the medication can be helpful. Withdrawal is part of management.
References
Zhang M, Holman CDJ, Preen DB, Brameld K. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. Br J Clin Pharmacol. 2007;63:163–70. [PMC free article] [PubMed] [Google Scholar]
Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLoS ONE. 2009;4:e4439.4. [PMC free article] [PubMed] [Google Scholar]
Hamilton HJ, Gallagher PF, O’Mohony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatrics. 2009;9:5. [PMC free article] [PubMed] [Google Scholar]
Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296:1858–66. [PubMed] [Google Scholar]
https://www.google.com/url?sa=i&url=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs41999-021-00481-9&psig=AOvVaw0cePGh3SVF9r5dv8hylaJ8&ust=1713790527836000&source=images&cd=vfe&opi=89978449&ved=0CBIQjRxqFwoTCLiAra-t04UDFQAAAAAdAAAAABAE
Amanda Hanora Lavan and Paul Gallagher. Predicting risk of adverse drug reactions in older adults https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716390/
Cassell A, Edwards D, Harshfield A, et al. The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract 2018; DOI: https://doi. org/10.3399/bjgp18X695465.
. Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One 2014; 9(7): e102149.
Peeters LEJ, Kester MP, Feyz L, et al. Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertension.Expert Opin Drug Metab Toxicol 2019; 15(4): 287–297.
Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf 2016; 7(1): 11–22.
Refbacks
- There are currently no refbacks.